Skip to content

Intelligent Activity-based Client-centred Training

Intelligent Activity-based Client-centred Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02982811
Acronym
i-ACT
Enrollment
47
Registered
2016-12-05
Start date
2017-03-01
Completion date
2020-06-26
Last updated
2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged, Central Nervous System Diseases

Keywords

Activity-based, Client-centred, Rehabilitation, Quality of life

Brief summary

The purpose of this study is to determine whether additional therapy with i-ACT system is effective in the training of functional skills in persons with central neurological diseases (e.g. multiple sclerosis, stroke, spinal cord injury, etc.).

Interventions

DEVICEi-ACT

3x 45 min training with i-ACT system (analytical and functional training) during 6 weeks, additional to therapy as usual (i.e. occupational therapy, physiotherapy, etc.)

Sponsors

Revalidatie & MS Centrum Overpelt
CollaboratorOTHER
Ziekenhuis Oost-Limburg
CollaboratorOTHER
Hasselt University
CollaboratorOTHER
PXL University College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Medical diagnosis of central nervous system disease (e.g. multiple sclerosis, stroke, spinal cord, etc.) * Be able to understand and respond to questions in Dutch * Actively involved in a rehabilitation programme in the participating rehabilitation centres * Have a dysfunction in upper and/or lower limb and/or core stability * Specifically for multiple sclerosis: min. of one month without corticosteroids * Specifically for stroke and spinal cord: min. 3 months post injury

Exclusion criteria

* Severe spasticity which prevent performing basic functional exercises * Severe cognitive and communicative impairment which prevent the person to understand and respond to Dutch instructions * Severe visual impairment, e.g. blindness, cataract, etc. * Pregnancy * Persons who use an electrical wheelchair, who can not transfer safely into a normal chair and perform the exercises

Design outcomes

Primary

MeasureTime frameDescription
Wolf Motor Function Test (WMFT)At baseline, after 3 and 6 weeks of training, and 6 weeks follow-upEvaluation of upper extremity
Short Form 36 (SF-36)At baseline, after 3 and 6 weeks of training, and 6 weeks follow-upEvaluation of general health status and quality of life

Secondary

MeasureTime frameDescription
Modified Fatigue Impact Scale (MFIS)At baseline, after 3 and 6 weeks of training, and 6 weeks follow-upEvaluation of fatigue
Trunk Impairment Scale (TIS)At baseline, after 3 and 6 weeks of training, and 6 weeks follow-upEvaluation of sitting, standing and core stability
Intrinsic Motivation Inventory (IMI)After 6 weeks of training, only persons in experimental groupEvaluation of motivation towards using the system in neurorehabilitation
Canadian Occupational Performance Measure (COPM)At baseline, after 6 weeks of training, and 6 weeks follow-upEvaluation of self-perception of performance of ADL tasks
Active Range of Motion (AROM)At baseline, after 3 and 6 weeks of training, and 6 weeks follow-upEvaluation of active range of motion
Manual Ability Measure (MAM-36)At baseline, after 3 and 6 weeks of training, and 6 weeks follow-upEvaluation of performance of manual tasks

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026